These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 17334966

  • 1. CD83: an update on functions and prospects of the maturation marker of dendritic cells.
    Prechtel AT, Steinkasserer A.
    Arch Dermatol Res; 2007 May; 299(2):59-69. PubMed ID: 17334966
    [Abstract] [Full Text] [Related]

  • 2. Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway.
    Schütz S, Chemnitz J, Spillner C, Frohme M, Hauber J, Kehlenbach RH.
    J Mol Biol; 2006 May 12; 358(4):997-1009. PubMed ID: 16580684
    [Abstract] [Full Text] [Related]

  • 3. CD83: a regulatory molecule of the immune system with great potential for therapeutic application.
    Fujimoto Y, Tedder TF.
    J Med Dent Sci; 2006 Jun 12; 53(2):85-91. PubMed ID: 16913569
    [Abstract] [Full Text] [Related]

  • 4. CD83 expression on dendritic cells and T cells: correlation with effective immune responses.
    Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, Bonehill A, Thielemans K, Breckpot K.
    Eur J Immunol; 2007 Mar 12; 37(3):686-95. PubMed ID: 17301951
    [Abstract] [Full Text] [Related]

  • 5. CD83 is a regulator of murine B cell function in vivo.
    Breloer M, Kretschmer B, Lüthje K, Ehrlich S, Ritter U, Bickert T, Steeg C, Fillatreau S, Hoehlig K, Lampropoulou V, Fleischer B.
    Eur J Immunol; 2007 Mar 12; 37(3):634-48. PubMed ID: 17266176
    [Abstract] [Full Text] [Related]

  • 6. CD83 regulates lymphocyte maturation, activation and homeostasis.
    Breloer M, Fleischer B.
    Trends Immunol; 2008 Apr 12; 29(4):186-94. PubMed ID: 18329338
    [Abstract] [Full Text] [Related]

  • 7. A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts.
    Xu JF, Huang BJ, Yin H, Xiong P, Feng W, Xu Y, Fang M, Zheng F, Wang CY, Gong FL.
    Transpl Int; 2007 Mar 12; 20(3):266-76. PubMed ID: 17291220
    [Abstract] [Full Text] [Related]

  • 8. Measurement of CD83 mRNA by real-time polymerase chain reaction to determine removal of dendritic cells by leucoreduction of whole blood.
    Morrison A, Macgregor I.
    Transfus Med; 2007 Jun 12; 17(3):175-81. PubMed ID: 17561858
    [Abstract] [Full Text] [Related]

  • 9. The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells.
    Kotzor N, Lechmann M, Zinser E, Steinkasserer A.
    Immunobiology; 2004 Jun 12; 209(1-2):129-40. PubMed ID: 15481147
    [Abstract] [Full Text] [Related]

  • 10. Eukaryotic expression of functionally active recombinant soluble CD83 from HEK 293T cells.
    Staab C, Mühl-Zürbes P, Steinkasserer A, Kummer M.
    Immunobiology; 2010 Jun 12; 215(9-10):849-54. PubMed ID: 20576314
    [Abstract] [Full Text] [Related]

  • 11. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
    Kuwano Y, Prazma CM, Yazawa N, Watanabe R, Ishiura N, Kumanogoh A, Okochi H, Tamaki K, Fujimoto M, Tedder TF.
    Int Immunol; 2007 Aug 12; 19(8):977-92. PubMed ID: 17804692
    [Abstract] [Full Text] [Related]

  • 12. Determination of the inhibitory activity and biological half-live of soluble CD83: comparison of wild type and mutant isoforms.
    Zinser E, Lechmann M, Golka A, Hock B, Steinkasserer A.
    Immunobiology; 2006 Aug 12; 211(6-8):449-53. PubMed ID: 16920484
    [Abstract] [Full Text] [Related]

  • 13. Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation.
    Dudziak D, Nimmerjahn F, Bornkamm GW, Laux G.
    J Immunol; 2005 Jun 01; 174(11):6672-6. PubMed ID: 15905506
    [Abstract] [Full Text] [Related]

  • 14. CD83 regulates splenic B cell maturation and peripheral B cell homeostasis.
    Lüthje K, Kretschmer B, Fleischer B, Breloer M.
    Int Immunol; 2008 Aug 01; 20(8):949-60. PubMed ID: 18544574
    [Abstract] [Full Text] [Related]

  • 15. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC, Andersson K, Josefsson E, Steinkasserer A, Rudin A.
    Infect Immun; 2007 Aug 01; 75(8):4097-104. PubMed ID: 17526743
    [Abstract] [Full Text] [Related]

  • 16. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population.
    Ju X, Silveira PA, Hsu WH, Elgundi Z, Alingcastre R, Verma ND, Fromm PD, Hsu JL, Bryant C, Li Z, Kupresanin F, Lo TH, Clarke C, Lee K, McGuire H, Fazekas de St Groth B, Larsen SR, Gibson J, Bradstock KF, Clark GJ, Hart DN.
    J Immunol; 2016 Dec 15; 197(12):4613-4625. PubMed ID: 27837105
    [Abstract] [Full Text] [Related]

  • 17. Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies.
    Lechmann M, Kremmer E, Sticht H, Steinkasserer A.
    Protein Expr Purif; 2002 Apr 15; 24(3):445-52. PubMed ID: 11922761
    [Abstract] [Full Text] [Related]

  • 18. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
    Li CD, Zhang WY, Yuan CL, Han LY.
    Zhonghua Yi Xue Za Zhi; 2009 Mar 10; 89(9):630-4. PubMed ID: 19595165
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA.
    Kruse M, Rosorius O, Krätzer F, Bevec D, Kuhnt C, Steinkasserer A, Schuler G, Hauber J.
    J Exp Med; 2000 May 01; 191(9):1581-90. PubMed ID: 10790432
    [Abstract] [Full Text] [Related]

  • 20. Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression.
    Chemnitz J, Pieper D, Grüttner C, Hauber J.
    Eur J Immunol; 2009 Jan 01; 39(1):267-79. PubMed ID: 19130553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.